However, baseline data from other groups showed that tumoral B7-H3 expression was higher in males, smokers, and more frequent in NSCLC patients with poor differentiation, larger tumor size, and wild-type EGFR [10, 12]. This evidence concerns the gene CD276 and non-small cell lung carcinoma.